SEC Filing Summary for IMMUTEP Ltd

This filing details the ownership of Stephan Karel Gerard Winckels, Chief Medical Officer of IMMUTEP Ltd. On October 13, 2025, Mr. Winckels was granted performance rights, with specific vesting dates and conditions outlined in the footnotes. These rights are convertible to Ordinary Shares. The filing also reports his direct ownership of 92,935 Ordinary Shares. The report date is March 18, 2026, and the signature date is April 1, 2026.